These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31138311)
1. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1. Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311 [TBL] [Abstract][Full Text] [Related]
2. BTF3-mediated regulation of BMI1 promotes colorectal cancer through influencing epithelial-mesenchymal transition and stem cell-like traits. Zhou W; Yun Z; Wang T; Li C; Zhang J Int J Biol Macromol; 2021 Sep; 187():800-810. PubMed ID: 34293363 [TBL] [Abstract][Full Text] [Related]
3. BTF3 promotes stemness and inhibits TypeⅠInterferon signaling pathway in triple-negative breast cancer. Wang H; Gao L; Qi M; Su P; Xiong X; Zhao J; Hu J; Han B Biochem Biophys Res Commun; 2021 Jan; 537():22-28. PubMed ID: 33383560 [TBL] [Abstract][Full Text] [Related]
4. CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c. Jiao M; Qi M; Zhang F; Hu J; Feng T; Zhao M; Li X; Liu H; Teng W; Zhang J; Liu Z; Zhang L; Wu Z; Han B Prostate; 2019 Aug; 79(11):1294-1303. PubMed ID: 31111526 [TBL] [Abstract][Full Text] [Related]
5. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties. Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455 [TBL] [Abstract][Full Text] [Related]
7. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Li X; Wu JB; Li Q; Shigemura K; Chung LW; Huang WC Oncotarget; 2016 Mar; 7(11):12869-84. PubMed ID: 26883200 [TBL] [Abstract][Full Text] [Related]
8. Insights into homeobox B9: a propeller for metastasis in dormant prostate cancer progenitor cells. Sui Y; Hu W; Zhang W; Li D; Zhu H; You Q; Zhu R; Yi Q; Tang T; Gao L; Zhu S; Yang T Br J Cancer; 2021 Sep; 125(7):1003-1015. PubMed ID: 34247196 [TBL] [Abstract][Full Text] [Related]
9. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein. Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675 [TBL] [Abstract][Full Text] [Related]
11. BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C. Zhang Y; Gao X; Yi J; Sang X; Dai Z; Tao Z; Wang M; Shen L; Jia Y; Xie D; Cheng H; Liu Z; Liu P Cell Death Dis; 2021 Jan; 12(1):12. PubMed ID: 33414468 [TBL] [Abstract][Full Text] [Related]
12. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180 [TBL] [Abstract][Full Text] [Related]
13. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449 [TBL] [Abstract][Full Text] [Related]
14. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway. Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383 [TBL] [Abstract][Full Text] [Related]
15. p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer. Sui X; Cai J; Li H; He C; Zhou C; Dong Y; Chen L; Zhang B; Wang Y; Zhang Y; Qiu Y; Zhang Y; Zhao Y; Huang Y; Shen Y; Wu H; Xiao J; Mason C; Zhu Q; Han S Cell Death Dis; 2018 May; 9(5):523. PubMed ID: 29743605 [TBL] [Abstract][Full Text] [Related]
16. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715 [TBL] [Abstract][Full Text] [Related]
17. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway. Li Q; Ye L; Guo W; Wang M; Huang S; Peng X J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312 [TBL] [Abstract][Full Text] [Related]
18. BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling. Siddique HR; Parray A; Tarapore RS; Wang L; Mukhtar H; Karnes RJ; Deng Y; Konety BR; Saleem M PLoS One; 2013; 8(5):e60664. PubMed ID: 23671559 [TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection. Wu KJ; Yang MH Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891 [TBL] [Abstract][Full Text] [Related]
20. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]